A new report released by Hevolution Foundation highlights that extending the number of years people live in good health is now one of the defining challenges for economies and societies worldwide.
The second edition of the Global Healthspan Report presents new evidence that aging, once seen as an inevitable decline, can be managed through science, policy, and innovation to drive sustainable growth and wellbeing. Drawing on two global surveys and extensive investment data, the report positions healthspan, the years of life spent in good health, as both a catalyst for scientific and economic progress.
The findings reveal the magnitude of what’s at stake:
- Reducing the period of poor health by just twelve months could generate trillions of dollars annually through higher productivity and lower healthcare costs.
- At the same time, global public demand for healthy longevity is rising fast, with more than half of respondents saying they would spend half their annual income on treatments that could add ten healthy years to their lives.
- Investment in healthspan-related innovation is accelerating. In 2024, global funding for healthspan science nearly doubled to $7.33 billion, with average deal sizes increasing by 77% compared to the previous year. The report argues that this surge signals growing investor confidence in an emerging sector poised to reshape the future of healthcare and aging.
“Extending healthy years of life is one of the defining challenges of our time,” said Dr. Mehmood Khan, CEO of Hevolution Foundation. “This report offers a roadmap for how science, policy, and investment can come together to make that vision real. Through our research funding and biotech investing led from Saudi Arabia, we are helping drive the global shift from simply adding years to life, to adding life to years, ensuring that healthier aging becomes a shared priority for all.”
The report also emphasizes the importance of global collaboration, highlighting how regions such as the Middle East are rapidly emerging as innovation hubs for healthspan science and policy. In Saudi Arabia, this vision aligns with Vision 2030 and the Kingdom’s ambition to become a global center for scientific and health innovation. Through Hevolution Foundation, Saudi Arabia has already allocated about $400 million toward advancing healthspan science, supporting over 230 research grants representing around 200 grantees worldwide, 25 strategic partnerships, and four biotech companies, all progressing toward human clinical translation.
The second edition of the Global Healthspan Report serves as a call to action for policymakers, scientists, and investors to align on a shared goal: extending healthy human lifespan, expanding access to innovation, and ensuring that longer, healthier lives become a global reality.
The full report is available for download at:
https://tinyurl.com/Global-Healthspan-Report-2025
About Hevolution Foundation
Established by Royal Order in 2018 and launched in 2021, Hevolution Foundation is a first-of-its kind global non-profit organization that incentives grants and early-stage investments to accelerate independent research and entrepreneurship in the emerging field of healthspan science. With a focus on aging as a treatable process, Hevolution aims to propel aging and geroscience research forward and support a cutting-edge global ecosystem of talent. Headquartered in Riyadh, Saudi Arabia, with a North American hub in Boston and plans for further international expansion, the Foundation has set key goals and targets to advance its Vision & Mission. Over the last three years, Hevolution has allocated over $400M in funding.
